UM Leads $12.3M Contract to Advance TB Vaccine
October 24, 2023
October 24, 2023
MISSOULA, Montana, Oct. 24 (TNSres) -- The University of Montana issued the following news release:
The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.
The five-year award went to UM's Center for Translational Medicine and its partners. The contract is titled "Development of UM . . .
The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.
The five-year award went to UM's Center for Translational Medicine and its partners. The contract is titled "Development of UM . . .